Product Information
OXCARBAZEPINE 300 MG/5 ML SUSP is a generic product labeled by Biocon Pharma Inc., priced at $0.1244 per ML under NDC 70377011711. Its NADAC has been published 90 times since Oct 9, 2024.
Strength
60 mg/mL
Manufacturer
Biocon Pharma Inc.NDC
70377011711
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OXCARBAZEPINEApproval Type
Generic (ANDA)
FDA Application
ANDA218278On Market Since
5/31/2024
Pharmacological Classes
Price Statistics
The NADAC for OXCARBAZEPINE 300 MG/5 ML SUSP has been published 90 times since Oct 9, 2024, and over the history we have for it it has declined 54.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1244 per ML |
|---|---|
| All-time high | $0.2704 (Oct 16, 2024) |
| All-time low | $0.1244 (Jun 17, 2026) |
| 52-week high | $0.2377 |
| 52-week low | $0.1244 |
| Median price | $0.1918 |
| Average price | $0.1887 |
| Largest weekly change | -18.4% (Nov 20, 2024) |
| Weeks tracked | 90 |
| Tracking since | Oct 9, 2024 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OXCARBAZEPINE 300 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for OXCARBAZEPINE 300 MG/5 ML SUSP, manufactured by Biocon Pharma Inc., is $0.1244 per ML (NDC 70377011711), effective Jun 24, 2026.
How has the price of OXCARBAZEPINE 300 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for OXCARBAZEPINE 300 MG/5 ML SUSP has declined 54.0%. It has been tracked across 90 weekly CMS publications since Oct 9, 2024.
What are the highest and lowest recorded NADAC prices for OXCARBAZEPINE 300 MG/5 ML SUSP?
Since Oct 9, 2024, the NADAC for OXCARBAZEPINE 300 MG/5 ML SUSP has ranged from a low of $0.1244 (Jun 17, 2026) to a high of $0.2704 (Oct 16, 2024), with a median of $0.1918 per ML.
Are there cheaper alternatives to OXCARBAZEPINE 300 MG/5 ML SUSP?
2 NADAC-published products share the same active ingredient, strength, and dosage form as OXCARBAZEPINE 300 MG/5 ML SUSP, but none are currently priced below it.
Who manufactures OXCARBAZEPINE 300 MG/5 ML SUSP?
OXCARBAZEPINE 300 MG/5 ML SUSP (NDC 70377011711) is labeled by Biocon Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification